Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cosmo Pharmaceuticals Announces Submission of Remimazolam NDA to FDA

drugsApril 17, 2019

Tag: Cosmo , Pharmaceuticals , FDA , NDA , colon

PharmaSources Customer Service